Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Karo Pharma SA (KARO)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
Karo Pharma historical data, for real-time data please try another search
60.70 +0.00    +0.00%
24/11 - Closed. Currency in SEK ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 60.40 - 61.00
Type:  Equity
Market:  Sweden
ISIN:  SE0007464888 
S/N:  273254604
Karo Pharma 60.70 +0.00 +0.00%

Karo Pharma Company Profile

 
Read the Karo Pharma SA company profile to learn more about the business and the management team. View Karo Pharma SA facts about employee data, company products and services, and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

369

Equity Type

ORD

Karo Healthcare AB, a healthcare company, develops and markets over-the-counter products and prescription drugs for pharmacies, digital distribution channels, and retail sector in Sweden, Norway, Denmark, Finland, France, Germany, Italy, the United Kingdom, rest of Europe, the United States, and internationally. It offers skin health products under the E45, Remescar, Locobase, Decubal, and indy beauty brand names; intimate health products under the Pevaryl, Multi Gyn, Asan, and Selexid brands; digestive products under the Scheriproct and Hemoproct brand names; and foot health products under the Pevaryl, Nailner, CCS, and wortie brands. The company also provides wellness products under the nutravita, Alpha Foods, Flux, Allévo, and Lactocare brand names; pain, cough, and cold products under the Paracet, Ibux, Mollipect, and Viruseptin brands; and specialty products under the Burinex, Centyl, Kaleorid, and Lithionit brand names. It sells its products in Europe and the Nordic region markets through direct sales organizations and a network of distributors, as well as online. Karo Healthcare AB was formerly known as Karo Pharma AB (publ). The company was incorporated in 1987 and is headquartered in Stockholm, Sweden. Karo Healthcare AB operates as a subsidiary of Karo Intressenter AB.

Contact Information

Address Klara Norra Kyrkogata 33
Stockholm, 111 22
Sweden
Phone 46 1 03 30 23 10
Fax -
Web www.karohealthcare.com
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

KARO Price Commentary

Write your thoughts about Karo Pharma SA
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email